ENDOXAN

This brand name is authorized in Austria, Australia, Cyprus, Germany, Ecuador, Estonia, France, Hong Kong, Croatia, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, South Africa

Active ingredients

The drug ENDOXAN contains one active pharmaceutical ingredient (API):

1 Cyclophosphamide monohydrate UNII 6UXW23996M - CYCLOPHOSPHAMIDE ANHYDROUS

Cyclophosphamide has been demonstrated to have a cytostatic effect in many tumour types. The active metabolites of cyclophosphamide are alkylating agents which transfer alkyl groups to DNA during the process of cell division, thus preventing normal synthesis of DNA. Read about Cyclophosphamide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01AA01	Cyclophosphamide	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AA Nitrogen mustard analogues
Discover more medicines within L01AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 4327R, 7226H
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00334534, 03141876, 04959337, 04959343, 11350192
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 12.869-4-07-06, 12.870-4-07-06
Country: EE	Ravimiamet	Identifier(s): 1021790, 1021802, 1021813, 1021824, 1124121
Country: FR	Base de données publique des médicaments	Identifier(s): 62554177, 64635418, 69586327
Country: HK	Department of Health Drug Office	Identifier(s): 01327, 51308, 51711
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-082504880, HR-H-141815990, HR-H-857890693, HR-H-921138904
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4080, 4081
Country: JP	医薬品医療機器総合機構	Identifier(s): 4211002F1044, 4211002X1023, 4211401D1033, 4211401D2021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1000705, 1000707, 1000708, 1004882, 1071140, 1079722, 1079980, 1079981, 1079982, 1080562, 1083567
Country: MT	Medicines Authority	Identifier(s): PI565/76701A
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 105333, 125164, 957
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 2694, 2695
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100022145, 100022151, 100022174, 100400618
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W12490001, W12491001, W12492001, W12493001, W64372001
Country: SG	Health Sciences Authority	Identifier(s): 00929P, 00930P, 01747P, 01748P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 2163031H, 2163032H, 2163133H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681413881039, 8681413881046, 8681413881053, 8681413881060
Country: ZA	Health Products Regulatory Authority	Identifier(s): A38/26/0593